Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Second cancers following antineoplastic therapy
F. Andrew Dorr, Charles A. Coltman
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Second cancers following antineoplastic therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Absence
20%
ABVD
20%
Alkylating Antineoplastic Agent
20%
Anticarcinogen
20%
Cancer
60%
Cancer Therapy
20%
Carcinogenesis
60%
Combination Therapy
100%
Comprehension
20%
Diseases
40%
Dose Response
40%
Evolution
20%
Exercise
20%
Hodgkin's Lymphoma
20%
Intensive Care
40%
Leukemia
20%
Malignant Neoplasm
60%
Man
40%
Patient
40%
Physician
20%
Procarbazine
20%
Radiation Exposure
20%
Radiation Therapy
40%
Second Cancer
20%
Survival
20%
Survival Rate
20%
Therapeutic Procedure
60%
Toxicity
20%
Treatment Duration
20%
Pharmacology, Toxicology and Pharmaceutical Science
Absence
20%
Alkylating Agent
20%
Anticarcinogen
20%
Carcinogenesis
60%
Chemotherapy
80%
Combination Therapy
20%
Diseases
40%
Hodgkin Disease
20%
Leukemia
20%
Malignant Neoplasm
60%
Procarbazine
20%
Radiation
40%
Radiation Exposure
20%
Second Cancer
20%
Survival
20%
Survival Rate
20%
Toxicity
20%